The PENTO Protocol in Medication-related Osteonecrosis of the Jaw
NCT05795647
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Medication-related Osteonecrosis of the Jaw (MRONJ)
Interventions
DRUG:
Pentoxifylline+Tocopherol
Sponsor
University Hospital, Limoges